Bernard E. Weissman

9.6k total citations · 1 hit paper
122 papers, 7.1k citations indexed

About

Bernard E. Weissman is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Bernard E. Weissman has authored 122 papers receiving a total of 7.1k indexed citations (citations by other indexed papers that have themselves been cited), including 108 papers in Molecular Biology, 41 papers in Pathology and Forensic Medicine and 25 papers in Oncology. Recurrent topics in Bernard E. Weissman's work include Chromatin Remodeling and Cancer (50 papers), Cancer Mechanisms and Therapy (39 papers) and Genomics and Chromatin Dynamics (14 papers). Bernard E. Weissman is often cited by papers focused on Chromatin Remodeling and Cancer (50 papers), Cancer Mechanisms and Therapy (39 papers) and Genomics and Chromatin Dynamics (14 papers). Bernard E. Weissman collaborates with scholars based in United States, Canada and France. Bernard E. Weissman's co-authors include Danny R. Welch, Eric J. Stanbridge, David Reisman, Karen Phillips, Stuart A. Aaronson, Jeffrey M. Trent, Weidong Wang, Erik S. Knudsen, Bryan L. Betz and Monica Miele and has published in prestigious journals such as Science, Cell and Proceedings of the National Academy of Sciences.

In The Last Decade

Bernard E. Weissman

113 papers receiving 7.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

KiSS-1, a Novel Human Malignant Melanoma Metastasis-Suppressor Gene

1996 831 citations Jeffrey M. Trent, Bernard E. Weissman et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Bernard E. Weissman United States	45	5.6k	1.6k	1.5k	926	852	122	7.1k
David W. Yandell United States	38	3.9k 0.7×	749 0.5×	3.1k 2.0×	954 1.0×	1.2k 1.4×	67	7.0k
Vundavalli V. Murty United States	40	4.4k 0.8×	1.2k 0.7×	1.9k 1.2×	862 0.9×	1.3k 1.6×	109	7.2k
Paul J. Goodfellow United States	51	5.1k 0.9×	2.7k 1.6×	2.8k 1.8×	2.2k 2.4×	3.0k 3.5×	222	11.1k
Giuliana Salvatore Italy	36	2.2k 0.4×	794 0.5×	2.0k 1.3×	754 0.8×	596 0.7×	83	5.3k
Katia Manova United States	47	7.4k 1.3×	336 0.2×	1.9k 1.3×	1.7k 1.9×	1.6k 1.9×	79	10.7k
Ruth Rimokh France	39	3.1k 0.6×	1.1k 0.7×	1.3k 0.8×	282 0.3×	849 1.0×	105	5.1k
Juan C. Cigudosa Spain	43	3.4k 0.6×	1.2k 0.7×	1.5k 1.0×	1.1k 1.2×	1.2k 1.5×	149	6.0k
Svetlana Pack United States	47	3.1k 0.6×	690 0.4×	1.5k 1.0×	1.1k 1.2×	1.1k 1.2×	130	6.5k
Martina Olivero Italy	33	3.0k 0.5×	572 0.3×	1.5k 1.0×	372 0.4×	813 1.0×	80	5.6k
S Munemitsu United States	24	5.1k 0.9×	1.1k 0.7×	1.3k 0.8×	893 1.0×	382 0.4×	28	7.1k

Countries citing papers authored by Bernard E. Weissman

Since Specialization

Citations

This map shows the geographic impact of Bernard E. Weissman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bernard E. Weissman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bernard E. Weissman more than expected).

Fields of papers citing papers by Bernard E. Weissman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bernard E. Weissman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bernard E. Weissman. The network helps show where Bernard E. Weissman may publish in the future.

Co-authorship network of co-authors of Bernard E. Weissman

This figure shows the co-authorship network connecting the top 25 collaborators of Bernard E. Weissman. A scholar is included among the top collaborators of Bernard E. Weissman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bernard E. Weissman. Bernard E. Weissman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Lang, Jessica D., Anthony N. Karnezis, F. Kommoss, et al.. (2025). Super-enhancers and efficacy of triptolide in small cell carcinoma of the ovary hypercalcemic type. iScience. 28(2). 111770–111770.

Jima, Dereje D., et al.. (2024). Mutant Nrf2E79Q enhances the promotion and progression of a subset of oncogenic Ras keratinocytes and skin tumors. Redox Biology. 75. 103261–103261. 3 indexed citations

Nguyen, Vinh T., Mathewos Tessema, & Bernard E. Weissman. (2023). The SWI/SNF Complex: A Frequently Mutated Chromatin Remodeling Complex in Cancer. Cancer treatment and research. 190. 211–244. 4 indexed citations

Song, Shujie, Vinh Nguyen, Travis P. Schrank, et al.. (2020). Loss of SWI/SNF Chromatin Remodeling Alters NRF2 Signaling in Non–Small Cell Lung Carcinoma. Molecular Cancer Research. 18(12). 1777–1788. 26 indexed citations

Tamir, Tigist Y., Brittany M. Bowman, Megan J. Agajanian, et al.. (2020). Gain-of-function genetic screen of the kinome reveals BRSK2 as an inhibitor of the NRF2 transcription factor. Journal of Cell Science. 133(14). 19 indexed citations

Tischkowitz, Marc, Sidong Huang, Susana Banerjee, et al.. (2020). Small-Cell Carcinoma of the Ovary, Hypercalcemic Type–Genetics, New Treatment Targets, and Current Management Guidelines. Clinical Cancer Research. 26(15). 3908–3917. 84 indexed citations

Wang, Yemin, Shane Colborne, Nancy Dos Santos, et al.. (2018). Histone Deacetylase Inhibitors Synergize with Catalytic Inhibitors of EZH2 to Exhibit Antitumor Activity in Small Cell Carcinoma of the Ovary, Hypercalcemic Type. Molecular Cancer Therapeutics. 17(12). 2767–2779. 52 indexed citations

Kuwahara, Yasumichi, Anthony N. Karnezis, E. Lorena Mora‐Blanco, et al.. (2018). High Frequency of Ovarian Cyst Development in Vhl;Snf5 Mice. American Journal Of Pathology. 188(7). 1510–1516.

Hepperla, Austin J., Vonn Walter, Shujie Song, et al.. (2014). BRG1/SMARCA4 Inactivation Promotes Non–Small Cell Lung Cancer Aggressiveness by Altering Chromatin Organization. Cancer Research. 74(22). 6486–6498. 102 indexed citations

10.

Wei, Darmood, Dennis Goldfarb, Shujie Song, et al.. (2014). SNF5/INI1 Deficiency Redefines Chromatin Remodeling Complex Composition during Tumor Development. Molecular Cancer Research. 12(11). 1574–1585. 28 indexed citations

11.

Song, Shujie, Vonn Walter, Mehmet Karaca, et al.. (2014). Gene Silencing Associated with SWI/SNF Complex Loss during NSCLC Development. Molecular Cancer Research. 12(4). 560–570. 20 indexed citations

12.

Kuwahara, Yasumichi, Aubri Charboneau, Erik S. Knudsen, & Bernard E. Weissman. (2010). Reexpression of hSNF5 in Malignant Rhabdoid Tumor Cell Lines Causes Cell Cycle Arrest through a p21CIP1/WAF1-Dependent Mechanism. Cancer Research. 70(5). 1854–1865. 37 indexed citations

13.

Chastain, Paul D., et al.. (2010). BRG1 co-localizes with DNA replication factors and is required for efficient replication fork progression. Nucleic Acids Research. 38(20). 6906–6919. 45 indexed citations

14.

Kuwahara, Yasumichi, E. Lorena Mora‐Blanco, Virginia Godfrey, et al.. (2009). Inactivation of SNF5 cooperates with p53 loss to accelerate tumor formation in Snf5^+/−;p53^+/− mice. Molecular Carcinogenesis. 48(12). 1139–1148. 18 indexed citations

15.

Clerck, Yves A. De, Bernard E. Weissman, Dihua Yu, et al.. (2006). Tumor progression and metastasis from genetic to microenvironmental determinants. Cancer Biology & Therapy. 5(12). 1588–1599. 1 indexed citations

16.

Link, Kevin A., Craig J. Burd, Erin Williams, et al.. (2005). BAF57 Governs Androgen Receptor Action and Androgen-Dependent Proliferation through SWI/SNF. Molecular and Cellular Biology. 25(6). 2200–2215. 100 indexed citations

17.

Reisman, David, et al.. (2005). The Expression of the SWI/SNF ATPase Subunits BRG1 and BRM in Normal Human Tissues. Applied immunohistochemistry & molecular morphology. 13(1). 66–74. 65 indexed citations

18.

Padalecki, Susan S., Korri Weldon, Carolyn L. Buller, et al.. (2003). Chromosome 18 suppresses prostate cancer metastases. Urologic Oncology Seminars and Original Investigations. 21(5). 366–373. 8 indexed citations

19.

Mayo, Marty W., Cun‐Yu Wang, Simon Drouin, et al.. (1999). WT1 modulates apoptosis by transcriptionally upregulating the bcl-2 proto-oncogene. The EMBO Journal. 18(14). 3990–4003. 202 indexed citations

20.

Fiore, Pier Paolo Di, Joseph Falco, Ivan Borrello, Bernard E. Weissman, & Stuart A. Aaronson. (1988). The Calcium Signal for BALB/MK Keratinocyte Terminal Differentiation Counteracts Epidermal Growth Factor (EGF) Very Early in the EGF-Induced Proliferative Pathway. Molecular and Cellular Biology. 8(2). 557–563. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact